Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Commercialization in 2026??

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Jan 03, 2023 4:41pm

218 Views

Post# 35201573

RE:Commercialization in 2026??

stocksnbonds, I was somewhat baffled by that statement as well. Dr. Mandel was talking about JV with big pharma in 2023, As we alll know that the Big Pharma likes to move to commercial stage as as they have FDA approval,

<< Previous

Bullboard Posts

Next >>

NTG Clarity Networks' growth story continues with $22M contract